14
Views
11
CrossRef citations to date
0
Altmetric
Research Article

Aripiprazole Augmentation in Treatment-Resistant Depression

, M.D., , M.D. & , M.A.
Pages 189-194 | Published online: 04 Dec 2011

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (11)

Changsu Han, Sheng-Min Wang, Masaki Kato, Soo-Jung Lee, Ashwin A Patkar, Prakash S Masand & Chi-Un Pae. (2013) Second-generation antipsychotics in the treatment of major depressive disorder: current evidence. Expert Review of Neurotherapeutics 13:7, pages 851-870.
Read now
Andrew A. Nierenberg, Madhukar H. Trivedi, Bradley N. Gaynes, Jeff Mitchell, Lori L. Davis, Mustafa M. Husain, Stephen R. Wisniewski, Maurizio Fava, Diane Warden, James F. Luther, Adrienne O. van Nieuwenhuizen, David W. Morris, Richard C. Shelton & A. John Rush. (2009) Effectiveness study of venlafaxine-XR combined with aripiprazole for chronic or recurrent major depressive disorder. Australian and New Zealand Journal of Psychiatry 43:10, pages 956-967.
Read now
J Craig Nelson, Andrei Pikalov & Robert M Berman. (2008) Augmentation treatment in major depressive disorder: focus on aripiprazole. Neuropsychiatric Disease and Treatment 4:5, pages 937-948.
Read now
Arif Khan. (2008) Current evidence for aripiprazole as augmentation therapy in major depressive disorder. Expert Review of Neurotherapeutics 8:10, pages 1435-1447.
Read now
David E. Kemp, David J. Muzina, Roger S. Mclntyre & Joseph R. Calabrese. (2008) Bipolar depression: trial-based insights to guide patient care. Dialogues in Clinical Neuroscience 10:2, pages 181-192.
Read now
Cornelius Schüle, Thomas C. Baghai, Daniela Eser, Susanne Hecht, Igor Hermisson, Christoph Born, Sibylle Häfner, Caroline Nothdurfter & Rainer Rupprecht. (2007) Mirtazapine monotherapy versus combination therapy with mirtazapine and aripiprazole in depressed patients without psychotic features: A 4-week open-label parallel-group study. The World Journal of Biological Psychiatry 8:2, pages 112-122.
Read now
Luiz Dratcu, Patricia Olowu, Muzafar Hawramy & Charitomeni Konstantinidou. (2006) Aripiprazole in the acute treatment of male patients with schizophrenia: effectiveness, acceptability, and risks in the inner-city hospital setting. Neuropsychiatric Disease and Treatment 2:2, pages 191-197.
Read now
Margarita García-Amador, Isabella Pacchiarotti, Marc Valentí, Raul F Sanchez, Jose M Goikolea & Eduard Vieta. (2006) Role of aripiprazole in treating mood disorders. Expert Review of Neurotherapeutics 6:12, pages 1777-1783.
Read now
Felicity Ng, Seetal Dodd & Michael Berk. (2006) Combination pharmacotherapy in unipolar depression. Expert Review of Neurotherapeutics 6:7, pages 1049-1060.
Read now
Terence A. Ketter, Po W. Wang, Rebecca A. Chandler, Jenifer L. Culver & Andrea M. Alarcon. (2006) Adjunctive Aripiprazole in Treatment-Resistant Bipolar Depression. Annals of Clinical Psychiatry 18:3, pages 169-172.
Read now
Warren A Kinghorn & Joseph P McEvoy. (2005) Aripiprazole: pharmacology, efficacy, safety and tolerability. Expert Review of Neurotherapeutics 5:3, pages 297-307.
Read now

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.